Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 4677-4684, September 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dlugosz, A. A.
Right arrow Articles by Yuspa, S. H.

Staurosporine Induces Protein Kinase C Agonist Effects and Maturation of Normal and Neoplastic Mouse Keratinocytes in Vitro

Andrzej A. Dlugosz1,2, and Stuart H. Yuspa

Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892

Staurosporine is a potent but nonselective inhibitor of protein kinase C (PKC) and blocks responses to 12-O-tetradecanoylphorbol-13-acetate (TPA) in several cell types in vitro. In cultured primary mouse keratinocytes, however, staurosporine fails to inhibit TPA-mediated keratinocyte maturation and itself elicits responses that are similar to TPA (T. Sako et al., Cancer Res., 48: 4646–4650, 1988). After exposure to 10 nM staurosporine for 24 h, essentially all keratinocytes undergo morphological differentiation, whereas 160 nM TPA induces this response in about 50% of epidermal cells. These concentrations of staurosporine and TPA cause a 4–5-fold induction of epidermal transglutaminase activity and cornified envelopes, both markers of the terminal stage of keratinocyte differentiation. Staurosporine, but not TPA, also induces morphological and biochemical maturation in 2 neoplastic mouse keratinocyte cell lines, 308 and SP-1. The ability of staurosporine to elicit the same responses as TPA suggested that it may be functioning paradoxically as a PKC agonist in intact keratinocytes. In support of this hypothesis, staurosporine induces ornithine decarboxylase activity, inhibits 125I-labeled epidermal growth factor binding, and induces expression of c-fos mRNA. Downregulation of PKC by pretreatment of primary keratinocytes with 60 nM bryostatin partially blocks staurosporine-mediated induction of cornified envelopes and inhibition of 125I-labeled epidermal growth factor binding, implicating PKC in these responses. The ability of staurosporine to mimic and/or enhance certain responses to TPA suggests that this agent is acting as a functional PKC agonist in cultured keratinocytes.

1 Recipient of a Physician's Research Training Fellowship (PRTF-98) from the American Cancer Society.

2 To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Building 37/Room 3B25, Bethesda, MD 20892.

Received 3/26/91. Accepted 6/14/91.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
L. Koivisto, K. Alavian, L. Hakkinen, S. Pelech, C. A. McCulloch, and H. Larjava
Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes
J. Cell Sci., September 15, 2003; 116(18): 3749 - 3760.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. A. Shapiro, S. Ray, E. Jung, W. T. Allred, and W. B. Bollag
Putative Conventional Protein Kinase C Inhibitor Godecke 6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Stimulates Transglutaminase Activity in Primary Mouse Epidermal Keratinocytes
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 352 - 358.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Li, P. S. Lorenzo, K. Bogi, P. M. Blumberg, and S. H. Yuspa
Protein Kinase Cdelta Targets Mitochondria, Alters Mitochondrial Membrane Potential, and Induces Apoptosis in Normal and Neoplastic Keratinocytes When Overexpressed by an Adenoviral Vector
Mol. Cell. Biol., December 1, 1999; 19(12): 8547 - 8558.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Jung, S. Betancourt-Calle, R. Mann-Blakeney, R. D. Griner, and W. B. Bollag
Sustained phospholipase D activation is associated with keratinocyte differentiation
Carcinogenesis, April 1, 1999; 20(4): 569 - 576.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Pedron, R. Girard, K. Inoue, D. Charon, and R. Chaby
Lipopolysaccharide and the Glycoside Ring of Staurosporine Induce CD14 Expression on Bone Marrow Granulocytes by Different Mechanisms
Mol. Pharmacol., October 1, 1997; 52(4): 692 - 700.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Gundimeda, Z.-H. Chen, and R. Gopalakrishna
Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-negative Breast Cancer Cells
J. Biol. Chem., June 7, 1996; 271(23): 13504 - 13514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.